Loading...
XETR
MRK
Market cap66bUSD
Jun 18, Last price  
133.05EUR
1D
-0.26%
1Q
27.87%
Jan 2017
34.19%
Name

Merck KGaA

Chart & Performance

D1W1MN
XETR:MRK chart
P/E
20.83
P/S
2.73
EPS
6.39
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
5.55%
Revenues
21.16b
+0.78%
5,870,300,0006,258,600,0007,057,100,0007,558,000,0007,747,000,0009,290,600,00010,276,400,00011,172,900,00011,095,100,00011,500,800,00012,844,700,00015,024,000,00015,327,000,00014,836,000,00016,152,000,00017,534,000,00019,687,000,00022,232,000,00020,993,000,00021,156,000,000
Net income
2.78b
-1.66%
658,900,000983,100,0003,500,100,000367,100,000366,300,000632,100,000606,500,000566,700,0001,202,200,0001,157,300,0001,115,000,0001,629,000,0002,605,000,0003,374,000,0001,320,000,0001,987,000,0003,055,000,0003,326,000,0002,824,000,0002,777,000,000
CFO
4.59b
+21.19%
732,500,000811,700,0001,218,300,0001,024,000,0001,371,300,0001,782,600,0001,271,200,0002,472,200,0002,225,500,0002,705,500,0002,195,200,0002,518,000,0002,696,000,0002,219,000,0002,856,000,0003,477,000,0004,616,000,0004,259,000,0003,784,000,0004,586,000,000
Dividend
Apr 28, 20250 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Globally, MERCK Kommanditgesellschaft auf Aktien conducts operations across the healthcare, life science, and electronics sectors. The company is actively involved in the research, development, production, and commercialization of both pharmaceutical and biological prescription medications. These treatments target a range of medical conditions, including those in neurology, immunology, oncology, fertility, and cardiometabolic and endocrine disorders. Furthermore, its life science division furnishes essential products, instruments, and services to support research facilities, pharmaceutical and biotechnology manufacturing, and industrial as well as analytical testing laboratories. Within its electronics segment, MERCK supplies crucial materials for integrated circuits, liquid crystals, organic light-emitting diodes (OLEDs), photoresists, smart antenna systems, and liquid crystal glazing solutions. It also produces specialized effect pigments extensively utilized in applications such as automotive coatings, cosmetics, and various industrial and plastics manufacturing. MERCK maintains strategic partnerships with Pfizer Inc., has an agreement with Novartis AG, and holds license arrangements with Debiopharm International SA and MoonLake Immunotherapeutics AG. Established in 1668, the firm's headquarters are located in Darmstadt, Germany, and it operates as a subsidiary of E. Merck Kommanditgesellschaft.
URL
https://www.emdgroup.com/
IPO date
Oct 20, 1995
Employees
59,308
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT